Rheumatic Heart Disease Emerges as a Silent Killer Among Uganda’s Young Population
Rheumatic heart disease is a preventable illness, yet it continues to threaten the lives of many young people in Uganda […]
Google News
RheumNow
🧠How well do you know this week’s rheumatology news? The RheumIQ Weekly Quiz is LIVE! ✅ Test your knowledge 📈
🧠How well do you know this week’s rheumatology news? The RheumIQ Weekly Quiz is LIVE! ✅ Test your knowledge
RheumNow
Teaching You How to Think… (8.15.2025) Dr. Jack Cush reviews the news, journal reports and press clippings from the
Teaching You How to Think… (8.15.2025) Dr. Jack Cush reviews the news, journal reports and press clippings from the https://pbs.twimg.com/profile_images/1915149062988271616/2m4z_QPt_normal.jpg
Rheumatology
Why noninferiority trials need improvement
The reporting methods of noninferiority randomized clinical trials are often inconsistent, with many publications omitting information crucial to clinical decision-making,
Google News
Patient-centred rheumatology research: evidence connects clinical practice and … – MedUni Wien
(Vienna, 19 August 2025) Three recent studies conducted by the Clinical Division of Rheumatology at MedUni Vienna’s Department of Internal …
Science Direct
Constitutional symptoms of severe childhood-onset polyarteritis nodosa
Publication date: September 2025 Source: The Lancet Rheumatology, Volume 7, Issue 9 Author(s): Pavneet Kaur, Srinivasavaradan Govindarajan, Manisha Jana, Aditi
Science Direct
The imaging crisis in axial spondyloarthritis
Publication date: September 2025 Source: The Lancet Rheumatology, Volume 7, Issue 9 Author(s): Torsten Diekhoff, Denis Poddubnyy
Science Direct
Effectiveness of treat-to-target tapering of TNF inhibitors for psoriatic arthritis and axial spondyloarthritis in the Netherlands: 24-month follow-up of the DRESS-PS trial
Publication date: September 2025 Source: The Lancet Rheumatology, Volume 7, Issue 9 Author(s): Amy C D Peeters, Celia A J
Science Direct
Comparison of findings on contrast-enhanced MRI of the hand, wrist, and forefoot in healthy controls, two at-risk groups, and patients with rheumatoid arthritis: a cohort study
Publication date: September 2025 Source: The Lancet Rheumatology, Volume 7, Issue 9 Author(s): Dennis A Ton, Nikolet K den Hollander,
Science Direct
Dual JAK and ROCK inhibition with CPL’116 in patients with rheumatoid arthritis with inadequate response to methotrexate: a randomised, double-blind, placebo-controlled, phase 2 trial
Publication date: September 2025 Source: The Lancet Rheumatology, Volume 7, Issue 9 Author(s): Maciej Wieczorek, Bartłomiej Kisiel, Dorota Włodarczyk, Piotr
Science Direct
Research in Brief
Publication date: September 2025 Source: The Lancet Rheumatology, Volume 7, Issue 9 Author(s): Jennifer Thorley
Science Direct
Long-term effectiveness of non-surgical interventions for chronic low back pain: a systematic review and meta-analysis
Publication date: September 2025 Source: The Lancet Rheumatology, Volume 7, Issue 9 Author(s): Hazel J Jenkins, Leticia Corrêa, Benjamin T
Science Direct
Preload deficiency as a treatable cause of fatigue and exercise intolerance in SLE
Publication date: September 2025 Source: The Lancet Rheumatology, Volume 7, Issue 9 Author(s): Yoo Jin Kim, Phebe Ismail, Michelle Petri,
Science Direct
Long-term outcomes in chronic low back pain: costs, comorbidities, and clinical importance
Publication date: September 2025 Source: The Lancet Rheumatology, Volume 7, Issue 9 Author(s): Jo Nijs, Elin Johansson
Science Direct
Exploring the specificity of MRI findings in rheumatoid arthritis
Publication date: September 2025 Source: The Lancet Rheumatology, Volume 7, Issue 9 Author(s): Mami Tamai, Atsushi Kawakami
Science Direct
Dual JAK and ROCK inhibition and comorbidities in rheumatoid arthritis
Publication date: September 2025 Source: The Lancet Rheumatology, Volume 7, Issue 9 Author(s): Fabiola Atzeni, James Galloway
Science Direct
Including refractory systemic sclerosis-associated GAVE in research agendas
Publication date: September 2025 Source: The Lancet Rheumatology, Volume 7, Issue 9 Author(s): Rushab C Shah, Laura J Ross, Maya
Science Direct
ILD in rheumatic disease: navigating complexity
Publication date: September 2025 Source: The Lancet Rheumatology, Volume 7, Issue 9 Author(s): The Lancet Rheumatology
Rheumatology
AIMed25 conference to cover entire ‘ecosystem of AI and health’
At this year’s AIMed25 conference, attendees will learn more about the future of AI in health care from industry leaders,
Google News
AWIR urges advocacy: ‘Crazy things’ at state level impact care – Healio
State legislatures have become the front lines in the battle for affordable medications and improved access to rheumatology care for
PubMed
Chondroitin Sulfate N-Acetylgalactosaminyltransferase 1 Promotes the Progression of Renal Fibrosis Mediated by Versican 1 in Mouse Remnant Kidney
Nephrology (Carlton). 2025 Aug;30(8):e70109. doi: 10.1111/nep.70109. ABSTRACT AIM: Renal fibrosis is a final common pathway for progressive chronic kidney diseases.
PubMed
Acute left heart failure is the initial manifestation of Takayasu arteritis: a case report
BMC Cardiovasc Disord. 2025 Aug 18;25(1):607. doi: 10.1186/s12872-025-05074-z. NO ABSTRACT PMID:40826383 | DOI:10.1186/s12872-025-05074-z
PubMed
Tophaceous gout in the lumbar spinal canal mimicking epidural spinal tumor in a male adolescent: A case report
Medicine (Baltimore). 2025 Aug 15;104(33):e43661. doi: 10.1097/MD.0000000000043661. ABSTRACT RATIONALE: Spinal gout is a rare occurrence, with varied symptoms based on
PubMed
Clinical characteristics and outcomes of anti-MDA5 dermatomyositis: a retrospective study
BMC Rheumatol. 2025 Aug 18;9(1):102. doi: 10.1186/s41927-025-00556-1. NO ABSTRACT PMID:40826379 | DOI:10.1186/s41927-025-00556-1
PubMed
Does Sulfasalazine Still Have Therapeutic Value in the Treatment of Axial Spondyloarthritis? A Real-World Cohort Study From China
J Evid Based Med. 2025 Aug 18:e70055. doi: 10.1111/jebm.70055. Online ahead of print. ABSTRACT OBJECTIVE: The efficacy of sulfasalazine (SSZ)
PubMed
Observation on the therapeutic effect of facial acupuncture combined with scalp Gua Sha in the treatment of facial paralysis
Medicine (Baltimore). 2025 Aug 15;104(33):e43546. doi: 10.1097/MD.0000000000043546. ABSTRACT Facial paralysis is a common neurological disorder that can result from various
PubMed
Genome-wide DNA methylation study reveals specific signatures in the affected arterial tissue of giant cell arteritis patients
Arthritis Rheumatol. 2025 Aug 18. doi: 10.1002/art.43358. Online ahead of print. ABSTRACT OBJECTIVES: Giant cell arteritis (GCA) is a large-vessel